Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform

Reuters12-05

Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform

Mirxes Holding Co. Ltd. has announced that it has entered into a memorandum of understanding (MOU) with XtalPi Holdings Limited. The collaboration aims to integrate Mirxes' genomics technology and extensive disease database focused on Asian populations with XtalPi's AI and robotics-driven drug discovery platform. Together, the companies plan to jointly develop an AI-enabled "integrated diagnosis and intervention" platform, with a focus on early detection and intervention for high-incidence gastrointestinal cancers in Asia. The partnership is expected to enhance research and development capabilities and support the long-term growth and revenue diversification of Mirxes Holding Co. Ltd., though the collaboration under the MOU is not guaranteed to proceed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251205-11946600), on December 05, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2589899581?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-05 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589899581","market":"fut","top_or_hot":-1,"title":"Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Mirxes Holding Co. Ltd. has announced that it has entered into a memorandum of understanding (MOU) with XtalPi Holdings Limited. The collaboration aims to integrate Mirxes' genomics technology and extensive disease database focused on Asian populations with XtalPi's AI and robotics-driven drug discovery platform. Together, the companies plan to jointly develop an AI-enabled \"integrated diagnosis and intervention\" platform, with a focus on early detection and intervention for high-incidence gastrointestinal cancers in Asia. The partnership is expected to enhance research and development capabilities and support the long-term growth and revenue diversification of Mirxes Holding Co. Ltd., though the collaboration under the MOU is not guaranteed to proceed.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251205-11946600), on December 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-05 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Mirxes Holding Co. Ltd. has announced that it has entered into a memorandum of understanding (MOU) with XtalPi Holdings Limited. The collaboration aims to integrate Mirxes' genomics technology and extensive disease database focused on Asian populations with XtalPi's AI and robotics-driven drug discovery platform. Together, the companies plan to jointly develop an AI-enabled \"integrated diagnosis and intervention\" platform, with a focus on early detection and intervention for high-incidence gastrointestinal cancers in Asia. The partnership is expected to enhance research and development capabilities and support the long-term growth and revenue diversification of Mirxes Holding Co. Ltd., though the collaboration under the MOU is not guaranteed to proceed.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251205-11946600), on December 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL62B2Jb:1","article_id":"2589899581","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589899581","pubTimestamp":1764932585,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Mirxes Holding Co. Ltd. has announced that it has entered into a memorandum of understanding  with XtalPi Holdings Limited. The collaboration aims to integrate Mirxes' genomics technology and extensive disease database focused on Asian populations with XtalPi's AI and robotics-driven drug discovery platform. Together, the companies plan to jointly develop an AI-enabled \"integrated diagnosis and intervention\" platform, with a focus on early detection and intervention for high-incidence gastrointestinal cancers in Asia. The partnership is expected to enhance research and development capabilities and support the long-term growth and revenue diversification of Mirxes Holding Co. Ltd., though the collaboration under the MOU is not guaranteed to proceed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should n","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02629":"MIRXES-B"},"translate_title":"Mirxes Holding Co.Ltd.与XtalPi签署人工智能驱动的癌症诊断和干预平台谅解备忘录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02629":0.9},"content_text":"Mirxes Holding Co. Ltd. Signs MOU with XtalPi for AI-Driven Cancer Diagnosis and Intervention Platform\n    \n\n        Mirxes Holding Co. Ltd. has announced that it has entered into a memorandum of understanding (MOU) with XtalPi Holdings Limited. The collaboration aims to integrate Mirxes' genomics technology and extensive disease database focused on Asian populations with XtalPi's AI and robotics-driven drug discovery platform. Together, the companies plan to jointly develop an AI-enabled \"integrated diagnosis and intervention\" platform, with a focus on early detection and intervention for high-incidence gastrointestinal cancers in Asia. The partnership is expected to enhance research and development capabilities and support the long-term growth and revenue diversification of Mirxes Holding Co. Ltd., though the collaboration under the MOU is not guaranteed to proceed.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251205-11946600), on December 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2589899581","isCrawlerRequest":true}